RYTM: Rhythm Pharmaceuticals Inc. Stocks News on July 13, 2025

Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025

RYTM

GlobeNewswire

18 days ago

Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025

This IBD 50 Biotech's Got 'Rhythm' — And Flashes 3 Telltale Clues

RYTM

Investor's Business Daily

a month ago

This IBD 50 Biotech's Got 'Rhythm' — And Flashes 3 Telltale Clues

RYTM

Insider Monkey

a month ago

Jefferies Maintains Buy Rating on Rhythm Pharmaceuticals (RYTM), Sets $80 Price Target

RYTM

Newsfile

a month ago

Sienna Resources Inc. Announces Private Placement

RYTM

Energy Global

a month ago

European Energy completes sale of Polish wind portfolio to Enea Group

RYTM

Newsfile

a month ago

Carbone Restaurant Group is a GOLD Sponsor at the Centurion One Capital 6th Annual LA Summit

RYTM

Newsfile

a month ago

Max Resource Corp. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

First Foundation Bank review (2025): Personal and business banking with competitive online rates

RYTM

Yahoo Personal Finance

a month ago

First Foundation Bank review (2025): Personal and business banking with competitive online rates

RYTM

Investing.com

a month ago

Airbnb shares dip as Truist cuts stock to Sell on weak summer trends, valuation

Report: Slower economy doesn't dim downtown Austin's dynamism

RYTM

Austin American-Statesman

a month ago

Report: Slower economy doesn't dim downtown Austin's dynamism

Nvidia (NVDA) Gets Wall Street Boost on Strong Q1 Results and Upbeat Guidance

RYTM

GuruFocus.com

a month ago

Nvidia (NVDA) Gets Wall Street Boost on Strong Q1 Results and Upbeat Guidance

Funds Go All In On Weight-Loss Leader; Stock Nears Highs

RYTM

Investor's Business Daily

a month ago

Funds Go All In On Weight-Loss Leader; Stock Nears Highs

Exploring 3 High Growth Tech Stocks In The US Market

RYTM

Simply Wall St.

2 months ago

Exploring 3 High Growth Tech Stocks In The US Market

Rhythm Pharmaceuticals Announces New Data Presentations on Patients with Acquired or Congenital Hypothalamic Obesity (N=35) Treated with Setmelanotide for up to Nine Months in French Early-access Program

RYTM

GlobeNewswire

2 months ago

Rhythm Pharmaceuticals Announces New Data Presentations on Patients with Acquired or Congenital Hypothalamic Obesity (N=35) Treated with Setmelanotide for up to Nine Months in French Early-access Program

RYTM

GuruFocus.com

2 months ago

Rhythm Pharmaceuticals Inc (RYTM) Q1 2025 Earnings Call Highlights: Strong IMCIVREE Sales and ...

RYTM

Zacks

2 months ago

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates

RYTM

MT Newswires

2 months ago

Rhythm Pharmaceuticals' Q1 Net Loss Narrows, Revenue Increases

Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update

RYTM

GlobeNewswire

2 months ago

Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

RYTM

GlobeNewswire

2 months ago

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

RYTM

MT Newswires

2 months ago

Rhythm Pharmaceuticals Insider Sold Shares Worth $438,946, According to a Recent SEC Filing

RYTM

MT Newswires

2 months ago

Rhythm Pharmaceuticals Insider Sold Shares Worth $457,663, According to a Recent SEC Filing

Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for

RYTM

Zacks

2 months ago

Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for

RYTM

Zacks

2 months ago

Will Rhythm Pharmaceuticals, Inc. (RYTM) Report Negative Earnings Next Week? What You Should Know

RYTM

Zacks

3 months ago

Rhythm Pharmaceuticals (RYTM) Moves 5.2% Higher: Will This Strength Last?

Rhythm Pharmaceuticals to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

RYTM

GlobeNewswire

3 months ago

Rhythm Pharmaceuticals to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

RYTM

MT Newswires

3 months ago

Rhythm Pharmaceuticals Insider Sold Shares Worth $1,082,497, According to a Recent SEC Filing

RYTM

MT Newswires

3 months ago

Rhythm Pharmaceuticals Insider Sold Shares Worth $1,248,490, According to a Recent SEC Filing

Rhythm Pharmaceuticals Stock Earns RS Rating Upgrade

RYTM

Investor's Business Daily

3 months ago

Rhythm Pharmaceuticals Stock Earns RS Rating Upgrade

5 Stocks in Nasdaq ETF Fueling Index's Big Comeback Since 2008

RYTM

Zacks

3 months ago

5 Stocks in Nasdaq ETF Fueling Index's Big Comeback Since 2008

RYTM

Zacks

3 months ago

RYTM Stock Rises 17% on Meeting Goals in Hypothalamic Obesity Study

RYTM

MT Newswires

3 months ago

Morgan Stanley Raises Price Target on Rhythm Pharmaceuticals to $77 From $72, Keeps Overweight Rating

RYTM

Zacks

3 months ago

Rhythm Pharmaceuticals (RYTM) Surges 17.1%: Is This an Indication of Further Gains?

RYTM

Simply Wall St.

3 months ago

Exploring 3 High Growth Tech Stocks In The US Market

This Obesity Drug Just Crushed Expectations -- And Sent One Biotech Stock Soaring 14.5%

RYTM

GuruFocus.com

3 months ago

This Obesity Drug Just Crushed Expectations -- And Sent One Biotech Stock Soaring 14.5%

Rhythm seeks market expansion for Imcivree following Phase III victory

RYTM

Clinical Trials Arena

3 months ago

Rhythm seeks market expansion for Imcivree following Phase III victory

Rhythm Pharmaceuticals Weight Loss Drug Study Shows Significant BMI Reduction For Rare Type Of Obesity Disorder

RYTM

Benzinga

3 months ago

Rhythm Pharmaceuticals Weight Loss Drug Study Shows Significant BMI Reduction For Rare Type Of Obesity Disorder

Obesity drug data helps Rhythm defy market slide

RYTM

BioPharma Dive

3 months ago

Obesity drug data helps Rhythm defy market slide

RYTM

MT Newswires

3 months ago

Rhythm Pharmaceuticals' Obesity Treatment Meets Main Goal in Phase 3 Study, Shares Rise

Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity

RYTM

GlobeNewswire

3 months ago

Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with Acquired Hypothalamic Obesity

RYTM

GlobeNewswire

3 months ago

Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with Acquired Hypothalamic Obesity

RYTM

MT Newswires

4 months ago

Rhythm Pharmaceuticals Regains Licensing Rights to Imcivree Obesity Drug

RYTM

Insider Monkey

4 months ago

Is Rhythm Pharmaceuticals (RYTM) a Worst High-Risk High-Reward Growth Stock to Buy?

Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd.

RYTM

GlobeNewswire

4 months ago

Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd.

RYTM

MT Newswires

4 months ago

Rhythm Gets Orphan Drug Label for Setmelanotide in Japan

Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan

RYTM

GlobeNewswire

4 months ago

Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan

RYTM

MT Newswires

4 months ago

Rhythm Pharmaceuticals Insider Sold Shares Worth $3,861,272, According to a Recent SEC Filing

Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration

RYTM

GlobeNewswire

4 months ago

Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration

US High Growth Tech Stocks to Watch in March 2025

RYTM

Simply Wall St.

4 months ago

US High Growth Tech Stocks to Watch in March 2025

RYTM

Simply Wall St.

5 months ago

We Think Rhythm Pharmaceuticals (NASDAQ:RYTM) Can Afford To Drive Business Growth

Rhythm Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line

RYTM

Simply Wall St.

5 months ago

Rhythm Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line

RYTM

GuruFocus.com

5 months ago

Rhythm Pharmaceuticals Inc (RYTM) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

RYTM

Thomson Reuters StreetEvents

5 months ago

Q4 2024 Rhythm Pharmaceuticals Inc Earnings Call

RYTM

Zacks

5 months ago

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Tops Revenue Estimates

RYTM

MT Newswires

5 months ago

Rhythm Pharmaceuticals Q4 Loss Widens, Revenue Increases

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update

RYTM

GlobeNewswire

5 months ago

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update

These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50

RYTM

Investor's Business Daily

5 months ago

These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

RYTM

Zacks

5 months ago

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on Wednesday, February 26, 2025

RYTM

GlobeNewswire

5 months ago

Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on Wednesday, February 26, 2025

Rhythm Pharmaceuticals to Present at Oppenheimer Annual Healthcare Life Sciences Conference in February

RYTM

GlobeNewswire

5 months ago

Rhythm Pharmaceuticals to Present at Oppenheimer Annual Healthcare Life Sciences Conference in February

RYTM

Zacks

5 months ago

Wall Street Analysts Think Rhythm Pharmaceuticals (RYTM) Could Surge 26.36%: Read This Before Placing a Bet

Exploring High Growth Tech Stocks in January 2025

RYTM

Simply Wall St.

6 months ago

Exploring High Growth Tech Stocks in January 2025

RYTM

Zacks

6 months ago

Rhythm Pharmaceuticals (RYTM) Soars 5.5%: Is Further Upside Left in the Stock?

Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming Milestones

RYTM

GlobeNewswire

6 months ago

Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming Milestones

Jefferies starts Rhythm Pharmaceuticals with Buy on obesity potential

RYTM

TipRanks

6 months ago

Jefferies starts Rhythm Pharmaceuticals with Buy on obesity potential

RYTM

MT Newswires

6 months ago

Jefferies Initiates Rhythm Pharmaceuticals at Buy With $80 Price Target

Exploring 3 High Growth Tech Stocks In The United States

RYTM

Simply Wall St.

7 months ago

Exploring 3 High Growth Tech Stocks In The United States

RYTM

Simply Wall St.

7 months ago

Rhythm Pharmaceuticals' (NASDAQ:RYTM) investors will be pleased with their incredible 370% return over the last three years

RYTM

MT Newswires

7 months ago

Rhythm Pharmaceuticals Gains FDA Approval for Expanded IMCIVREE Use

Rhythm Pharmaceuticals' Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential

RYTM

Benzinga

7 months ago

Rhythm Pharmaceuticals' Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old

RYTM

GlobeNewswire

7 months ago

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old

RYTM

MT Newswires

7 months ago

Oppenheimer Initiates Coverage on Rhythm Pharmaceuticals With Outperform Rating, $76 Price Target

Rhythm Pharmaceuticals price target raised to $75 from $64 at JMP Securities

RYTM

TipRanks

7 months ago

Rhythm Pharmaceuticals price target raised to $75 from $64 at JMP Securities

RYTM

MT Newswires

7 months ago

Rhythm Pharmaceuticals Says Imcivree Receives Expanded Marketing Authorization in UK

Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency to include Children as Young as 2 Years Old

RYTM

GlobeNewswire

7 months ago

Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency to include Children as Young as 2 Years Old

Biotech Stock Attempts To End Losing Streak, Lands Back in Buy Zone

RYTM

Investor's Business Daily

8 months ago

Biotech Stock Attempts To End Losing Streak, Lands Back in Buy Zone

Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide

RYTM

GlobeNewswire

8 months ago

Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide

Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology

RYTM

GlobeNewswire

8 months ago

Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

RYTM

GlobeNewswire

8 months ago

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

High Growth Tech Stocks Featuring Three Prominent US Companies

RYTM

Simply Wall St.

8 months ago

High Growth Tech Stocks Featuring Three Prominent US Companies

Rhythm Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

RYTM

Simply Wall St.

8 months ago

Rhythm Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

RYTM

GuruFocus.com

8 months ago

Rhythm Pharmaceuticals Inc (RYTM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

RYTM

GlobeNewswire

8 months ago

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

RYTM

Zacks

8 months ago

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Tops Revenue Estimates

Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update

RYTM

GlobeNewswire

8 months ago

Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update

Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024

RYTM

GlobeNewswire

8 months ago

Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024

Will Allogene Therapeutics (ALLO) Report Negative Earnings Next Week? What You Should Know

RYTM

Zacks

8 months ago

Will Allogene Therapeutics (ALLO) Report Negative Earnings Next Week? What You Should Know

RYTM

Zacks

8 months ago

Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

ImmunityBio (IBRX) Soars 26.4%: Is Further Upside Left in the Stock?

RYTM

Zacks

8 months ago

ImmunityBio (IBRX) Soars 26.4%: Is Further Upside Left in the Stock?

Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome

RYTM

GlobeNewswire

9 months ago

Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome

Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024

RYTM

GlobeNewswire

9 months ago

Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024

RYTM

MT Newswires

9 months ago

Guggenheim Initiates Coverage on Rhythm Pharmaceuticals With Buy Rating, $70 Price Target

High Growth Tech Stocks to Watch in October 2024

RYTM

Simply Wall St.

9 months ago

High Growth Tech Stocks to Watch in October 2024

RYTM

GlobeNewswire

9 months ago

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

RYTM

Insider Monkey

10 months ago

Rhythm Pharmaceuticals, Inc. (RYTM): Short Seller Sentiment is Bearish

RYTM

Zacks

10 months ago

Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 7.4% Jump Turn into More Strength?

RYTM

MT Newswires

10 months ago

HC Wainwright Initiates Rhythm Pharmaceuticals at Buy

RYTM

MT Newswires

10 months ago

Rhythm Pharmaceuticals Shares Rise After JMP Securities Initiates Coverage at Outperform

RYTM

MT Newswires

10 months ago

JMP Securities Initiates Rhythm Pharmaceuticals at Outperform

RYTM

GlobeNewswire

10 months ago

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

Biotech Stock Near Buy Point Amid Impressive Sales Track Record

RYTM

Investor's Business Daily

10 months ago

Latest Rhythm Pharmaceuticals Inc. (RYTM) News on July 13, 2025

Share on Social Networks: